Research News and Research

RSS

Newer clot-busting drug may lengthen the window for additional stroke treatment to 24 hours

If patients with clot-caused strokes obtain medical care more than 4½ hours after their symptoms are noticed, it is too late to receive the standard clot-busting medication alteplase.

11 Feb 2022

Survey demonstrates financial and mental health damage that may outlive the COVID threat

New Yorkers entering their third year of COVID have bleak views of the near-term economy and a strong conviction that vaccines should be required for those seeking to participate in their city's indoor activities (69%), to work in its service industries (66%) or schools (69%), and even to travel on airplanes (68%).

11 Feb 2022

Alkem signs license agreement with Harvard to develop, commercialize new technology for treating ischemic conditions

Alkem Laboratories Limited, an Indian multinational pharmaceutical company, has signed a license agreement with Harvard University's Office of Technology Development enabling Alkem to develop and commercialize a novel technology that may help meet the dire need for effective treatment of diabetic neuropathy, foot ulcers, peripheral arterial disease (PAD), and other injuries caused by vascular disease.

11 Feb 2022

Scientific statement highlights the uncertainty about health effects of marijuana

Despite the perception that marijuana is harmless, there is some scientific evidence challenging that belief, and there are many unanswered questions about its impact on brain health, according to a new American Heart Association scientific statement published today in the Association's journal Stroke.

10 Feb 2022

Molecular treatment works against metastatic cancer that spread to the brain

Mount Sinai researchers conducting clinical trials of a drug targeting a cancer gene found that it increased metastatic cancer patients' survival and was able to work within the brain, according to a study published in Clinical Cancer Research in February.

10 Feb 2022

Scientists discover a new class of potential drug targets for neurodegenerative diseases

Oregon State University scientists have discovered a new class of potential drug targets for people suffering from neurodegenerative conditions such as Alzheimer's, Parkinson's and Lou Gehrig's disease.

10 Feb 2022

Lower income populations face higher exposure to heat waves, study shows

People with lower incomes are exposed to heat waves for longer periods of time compared to their higher income counterparts due to a combination of location and access to heat adaptations like air conditioning.

10 Feb 2022

Novel molecule shows ability to inhibit the replication of all coronaviruses

Uppsala researchers have succeeded in designing a molecule that inhibits the replication of coronaviruses and that has great potential for development into a drug suitable for treating COVID-19.

10 Feb 2022

Drugs used to increase insulin signaling may be effective therapeutic strategy for autism

Drugs to increase insulin signaling may be effective for treating autism say Lancaster University researchers, who have discovered how a genetic change impacts on insulin signaling and glucose metabolism in the brain.

10 Feb 2022

Artificial intelligence uses facial features to better diagnose rare genetic diseases

Rare genetic diseases can sometimes be recognized through facial features, such as characteristically shaped brows, nose or cheeks.

10 Feb 2022

Case study: COVID-19 preventive behaviors impacted by implicit social pressure, desire for normalcy

As we move into the third year of the COVID-pandemic, we still face a multitude of information and it can be hard to know what guidelines to follow.

10 Feb 2022

Being fit can protect older people against mild cognitive impairment

Seventy- to eighty-year-olds who train for better fitness are better at solving cognitive tasks and are less likely to suffer cognitive impairment.

10 Feb 2022

Scientists introduce a genetic mutation to provide protection against Alzheimer's disease

Researchers from the Université Laval Faculty of Medicine and CHU de Québec–Université Laval Research Centre have successfully edited the genome of human cells grown in vitro to introduce a mutation providing protection against Alzheimer's disease.

10 Feb 2022

Study paves the way for efficient one-dose strategy to reduce scabies prevalence

One dose of an anti-parasite drug was just as effective as two at significantly reducing the spread of scabies, the contagious, intensely itchy skin condition, according to a new study.

10 Feb 2022

Simple eye test may help identify Alzheimer’s risk in middle age

A simple eye test may make diagnosing the earliest stages of 'diseases of old age' possible when people are much younger, University of Otago researchers hope.

10 Feb 2022

Gene variants associated with acute kidney injury in Black veterans hospitalized with COVID-19

Gene variants increased the risk of acute kidney injury and death in veterans of African ancestry who were hospitalized with COVID-19, according to a new study published in JAMA Internal Medicine.

10 Feb 2022

Epigenetic effects of pollutants may persist long enough to influence the evolutionary process

A new study led by University of Liverpool researchers has shown that the effects of pollutants can be transmitted over many generations in water fleas and may persist long enough to influence the evolutionary process.

10 Feb 2022

Stress created by police violence may affect Black women’s perinatal and cardiovascular health

It is well known that Black women experience disproportionately high rates of preterm delivery and cardiovascular disease.

10 Feb 2022

Unavailability of COVID-19 testing linked to greater intentions to engage in risky behavior

A research survey of more than 1,100 people in the United States found that when COVID-19 testing wasn't available in their community, participants showed significantly greater intentions to engage in risky behavior, possibly leading to increased transmission of the virus.

10 Feb 2022

Study identifies SARS-CoV-2 variants with potential to escape the immune system's T cell response

A number of existing strains of SARS-CoV-2, as well as other future variants that could arise, have the potential to escape the immune system's cytotoxic T cell response in some portion of the population.

10 Feb 2022

Research News and Research

Newer clot-busting drug may lengthen the window for additional stroke treatment to 24 hours

Survey demonstrates financial and mental health damage that may outlive the COVID threat

Alkem signs license agreement with Harvard to develop, commercialize new technology for treating ischemic conditions

Scientific statement highlights the uncertainty about health effects of marijuana

Molecular treatment works against metastatic cancer that spread to the brain

Scientists discover a new class of potential drug targets for neurodegenerative diseases

Lower income populations face higher exposure to heat waves, study shows

Novel molecule shows ability to inhibit the replication of all coronaviruses

Drugs used to increase insulin signaling may be effective therapeutic strategy for autism

Artificial intelligence uses facial features to better diagnose rare genetic diseases

Case study: COVID-19 preventive behaviors impacted by implicit social pressure, desire for normalcy

Being fit can protect older people against mild cognitive impairment

Scientists introduce a genetic mutation to provide protection against Alzheimer's disease

Study paves the way for efficient one-dose strategy to reduce scabies prevalence

Simple eye test may help identify Alzheimer’s risk in middle age

Gene variants associated with acute kidney injury in Black veterans hospitalized with COVID-19

Epigenetic effects of pollutants may persist long enough to influence the evolutionary process

Stress created by police violence may affect Black women’s perinatal and cardiovascular health

Unavailability of COVID-19 testing linked to greater intentions to engage in risky behavior

Study identifies SARS-CoV-2 variants with potential to escape the immune system's T cell response

New Approach Methodologies, the 3Rs and Multimodal Imaging in Preclinical Research - eBook eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence